Waypoint Bio

Series-A
waypointbio.com Biotech & Healthcare
Total Funding $20M
Latest Round $20M Series-A
Last Announced Jun 1, 2026
Investors Undisclosed
Decision Makers 6 Verified

About Waypoint Bio

Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website waypointbio.com
Domain Registered Date Apr 25, 2021

Social & Network Presence

X / Twitter Profile @waypointbio (142 followers) Created on Jun 2021
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $20,000,000 · Series-A

    fundraisingfox.com

  2. Capital Raise

    Seed announced

    fundraisingfox.com

  3. Milestone

    X account created (@waypointbio)

    142 followers

  4. Milestone

    Website domain registered

    waypointbio.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Waypoint Bio.

Funding History

2 Rounds
Series-A · Jun 1, 2026
Seed · Jun 28, 2024

Founders & Leadership

2

David Phizicky

Co-founder & CSO

Work email & phone locked Unlock →

Xinchen Wang

Co-founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts